[Thrombocytopenia in patients with chronic hepatitis C]
- PMID: 20731135
[Thrombocytopenia in patients with chronic hepatitis C]
Abstract
This article represented a modern view on the problem of thrombocytopenia in patients with chronic hepatitis C, including it's role as an adverse event of antiviral therapy. According to the literature the prevalence was analyzed and the main aspects of pathogenesis, possible ways of treatment of thrombocytopenia were discussed.
Similar articles
-
Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.Eur J Dermatol. 2006 Sep-Oct;16(5):579-80. Eur J Dermatol. 2006. PMID: 17101483 No abstract available.
-
Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.J Am Acad Dermatol. 2004 Apr;50(4):649-50. doi: 10.1016/j.jaad.2003.06.013. J Am Acad Dermatol. 2004. PMID: 15034524 No abstract available.
-
Peginterferon and ribavirin for chronic hepatitis C.N Engl J Med. 2006 Dec 7;355(23):2444-51. doi: 10.1056/NEJMct061675. N Engl J Med. 2006. PMID: 17151366 Review. No abstract available.
-
Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.Aliment Pharmacol Ther. 2013 Feb;37(4):492. doi: 10.1111/apt.12189. Aliment Pharmacol Ther. 2013. PMID: 23336679 No abstract available.
-
[Combination therapy for chronic viral hepatitis C].Dtsch Med Wochenschr. 2003 Feb 21;128(8):370-4. doi: 10.1055/s-2003-37369. Dtsch Med Wochenschr. 2003. PMID: 12594622 Review. German. No abstract available.